Top cardiac electrophysiology congresses join forces

June 13, 2012

Nice, 13 June 2012: Europe's leading congresses in cardiac electrophysiology have agreed to hold a joint annual Congress during 2014-2017. The official agreement was signed by ESC-EHRA and CARDIOSTIM-REED on 13 June, during CARDIOSTIM 2012 in Nice, France, 13-16 June.

CARDIOSTIM is an international scientific congress in the field of electrophysiology and cardiac techniques. It is owned by Reed Exhibitions, subsidiary of Reed-Elsevier, and held every even numbered year in Nice since 1978.

The European Heart Rhythm Association (EHRA) is a registered branch of the (ESC). Its official meeting, EHRA EUROPACE, is an international conference on cardiac arrhythmias and takes place every odd numbered year in different member countries of the ESC.

Since 2006 EHRA and CARDIOSTIM have had an agreement to hold their respective congresses in alternating years and collaborate on the scientific programme. Under this new agreement, a joint Congress will now be held each year in June.

The of both organisations is to continue to hold a high quality scientific Congress that attracts the most eminent scientific specialists worldwide, reports on the latest news in the field, and provides top notch training to cardiology professionals.

While ESC-EHRA and CARDIOSTIM-REED will maintain their commercial and corporate independence, they have set up a joint Scientific Committee which will be responsible for establishing the scientific programme of the annual Congress. It will be led by two co-chairpersons, one from each organisation.

In 2014 and 2016 the Congress will be called CARDIOSTIM-EHRA EUROPACE. It will be organised by CARDIOSTIM-REED and the Scientific Committee will be run by the CARDIOSTIM-REED appointed Chairman.

In 2015 and 2017 the Congress will be called EHRA EUROPACE-CARDIOSTIM and will be organised by ESC-EHRA. In those years the Scientific Committee will be run by the ESC-EHRA appointed Chairman.

The Programme will be built around four main topics: electrophysiology (EP) and catheter ablation, devices, non-invasive EP and basic science. Every year the Congress abstracts will be published in EP-Europace — The European Journal of Pacing, Arrhythmias and , the official journal of EHRA, the ESC Working Group on Cardiac Cellular Electrophysiology, and the ESC Working Group on e-Cardiology.

"The scientific quality of the Congress programme is guaranteed through this contract and we avoid any conflict between the main European arrhythmias communities," says Professor Panos Vardas, ESC president elect and EHRA past president. "The industry is happy with this decision because it likes to have one well organised annual electrophysiology conference in Europe. This avoids difficult dilemmas in having to choose between CARDIOSTIM and EHRA EUROPACE."

Professor Angelo Auricchio, president of EHRA, says: "Having one will ensure the quality and also the high level of the scientific content. This is a great opportunity for the European electrophysiology community to have a large annual meeting. The will also be the annual event for the international electrophysiology community to learn about the scientific activity in Europe."

He adds: "For EHRA it's a unique opportunity to meet its own members every year and to disseminate information about the importance of diagnosing and improving treatment for patients with ."

Dr Philippe Ritter, as Cardiostim Chairman, says: "The combination of the scientific programme committees into a single entity will lead to an unrivalled educational offering. I am proud, as Chairman of Cardiostim, to have contributed to this significant understanding for which the European EP community has been waiting so long."

Michel Filzi, Reed General Manager, adds: "Our belief, as Cardiostim organiser, is that we are stronger together than apart. When shaping this agreement, we always kept in mind the interests of two stakeholders: the scientific community, who will benefit from the best of our two current congresses, and the industry which will still be assured of an efficient and adequate international meeting. As Cardiostim 2012 opens, we would like to stress, once more, the importance of sharing information and best practices on a really global scale, which is the essence of leading medical congresses."

Explore further: Innovations in anticoagulation for stroke prevention

Related Stories

Innovations in anticoagulation for stroke prevention

June 13, 2012
New scientific findings in anticoagulation for stroke prevention are paving the way for updates to the European Society of Cardiology (ESC) Guidelines for the management of atrial fibrillation.

European and Brazilian cardiologists cooperate to reduce cardiovascular deaths

September 12, 2011
Against a background of high mortality rates from cardiovascular disease (CVD) in Brazil, the European Society of Cardiology (ESC) is to deliver an educational programme at the 66th Annual Congress of the Brazilian Society ...

Increasing cardiovascular disease in China: Urgent need for prevention

October 12, 2011
At over 40%, the mortality rate due to cardiovascular disease (CVD) in China is amongst the highest in the world¹ and has been rightly described as an epidemic.

Genetic testing for inherited cardiac conditions is 'patchy' in Europe

June 27, 2011
While genetic inheritance is known to play a role in the multifactorial development of most diseases of the heart, there are also a number of clearly diagnosed cardiac conditions which owe their development to quite specific ...

Recommended for you

Could aggressive blood pressure treatments lead to kidney damage?

July 18, 2017
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

Quantifying effectiveness of treatment for irregular heartbeat

July 17, 2017
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the ...

Concerns over side effects of statins stopping stroke survivors taking medication

July 17, 2017
Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially ...

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Protein may protect against heart attack

July 14, 2017
DDK3 could be used as a new therapy to stop the build-up of fatty material inside the arteries

Heart study finds faulty link between biomarkers and clinical outcomes

July 14, 2017
Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.